Gladstone Investment (GAIN) Prices $65M Notes Offering

Gladstone Investment Corporation (Nasdaq: GAIN) today announced that it priced a public offering of $65.00 million aggregate principal amount of 8.00% Notes due 2028 on May 23, 2023. The Notes will mature on August 1, 2028 and may be redeemed in whole or in part at any time or from time to time at the Company's option on or after August 1, 2025. The Notes will bear interest at a rate of 8.00% per year payable quarterly on February 1, May 1, August 1 and November 1 of each year, beginning August 1, 2023. The Company also granted the underwriters a 30-day option to purchase up to an additional $9.75 million in aggregate principal amount of Notes to cover overallotments, if any. The Company expects to list the Notes on the Nasdaq Global Select Market under the trading symbol "GAINL" within 30 days of issuance. Oppenheimer & Co. Inc., B. Riley Securities, Inc., Janney Montgomery Scott LLC and Ladenburg Thalmann & Co. Inc. are acting as joint book-running managers for this offering. Piper Sandler & Co., Wedbush Securities Inc. and Gladstone Securities, LLC are acting as co-managers for this offering.

The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered on or about May 31, 2023.

The Company intends to use the net proceeds from this offering to repay a portion of the amount outstanding under its revolving credit facility, to fund new investment opportunities, and for other general corporate purposes.

Investors are advised to carefully consider the investment objectives, risks and charges and expenses of the Company before investing. The preliminary prospectus supplement, dated May 23, 2023, and the accompanying prospectus, dated October 15, 2021, which have been filed with the U.S. Securities and Exchange Commission (the "SEC"), contain this and other information about the Company and should be read carefully before investing.

The offering is being conducted as a public offering under the Company's effective shelf registration filed with the SEC (File No. 333-259302).

To obtain a copy of the preliminary prospectus supplement for this offering and the accompanying prospectus, please contact: Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 23rd Floor, New York, NY 10004 or by email at [email protected].

This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

You May Also Be Interested In

• Biolase (BIOL) Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
• Mercurity Fintech (MFH) Announces $6 Million Private Placement Financing
• Southwest Gas (SWX) Provides Update on Centuri